[{"Assets_0_Q2_USD":673329000.0,"CommonStockSharesOutstanding_0_Q2_shares":33179860.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":85268000.0,"NetIncomeLoss_2_Q2_USD":-31712000.0,"NetIncomeLoss_1_Q2_USD":-13060000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":136810000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":73061000.0,"StockholdersEquity_0_Q2_USD":82681000.0,"Ticker":"COLL","CIK":"1267565","name":"COLLEGIUM PHARMACEUTICAL, INC","OfficialName":"Collegium Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"619097451.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]